Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study

被引:2
作者
Mongraw-Chaffin, Morgana [1 ]
Saldana, Santiago [2 ]
Carnethon, Mercedes R. [3 ]
Chen, Haiying [2 ]
Effoe, Valery [4 ]
Golden, Sherita Hill [5 ]
Joseph, Joshua [6 ]
Kalyani, Rita R. [5 ]
Bertoni, Alain G. [1 ]
机构
[1] Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27157 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Morehouse Sch Med, Div Cardiol, Atlanta, GA 30310 USA
[5] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
关键词
type; 2; diabetes; metabolic syndrome; visceral fat normal weight; African American; BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; AFRICAN-AMERICANS; HEALTHY OBESITY; CONSEQUENCES; ACCUMULATION;
D O I
10.1210/jendso/bvac059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis. Objective: While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans. Methods: In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m(2)). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity. Results: Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D. Conclusion: Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Type 2 diabetes and atherosclerosis: Focusing on metabolic syndrome
    Katakami N.
    Kaneto H.
    Funahashi T.
    Shimomura I.
    Diabetology International, 2013, 4 (3) : 143 - 148
  • [42] A Pathophysiology of Type 2 Diabetes Unrelated to Metabolic Syndrome
    Rottenkolber, Marietta
    Gar, Christina
    Then, Cornelia
    Wanger, Lorena
    Sacco, Vanessa
    Banning, Friederike
    Potzel, Anne L.
    Kern-Matschilles, Stefanie
    Nevinny-Stickel-Hinzpeter, Claudia
    Grallert, Harald
    Hesse, Nina
    Seissler, Jochen
    Lechner, Andreas
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (05) : 1460 - 1471
  • [43] The metabolic syndrome is related to albuminuria in Type 2 diabetes
    Bianchi, C.
    Penno, G.
    Daniele, G.
    Russo, E.
    Giovannitti, M. G.
    Del Prato, S.
    Miccoli, R.
    DIABETIC MEDICINE, 2008, 25 (12) : 1412 - 1418
  • [44] Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes
    Gurka, Matthew J.
    Guo, Yi
    Filipp, Stephanie L.
    DeBoer, Mark D.
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [45] Epidemiology of the Metabolic Syndrome in Type 2 Diabetes in Germany
    Koehler, C.
    Hanefeld, M.
    DIABETES STOFFWECHSEL UND HERZ, 2008, 17 : S5 - S10
  • [46] Determinants of Increased Cardiovascular Disease in Obesity and Metabolic Syndrome
    Vazzana, N.
    Santilli, F.
    Sestili, S.
    Cuccurullo, C.
    Davi, G.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (34) : 5267 - 5280
  • [47] Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity, Metabolic Syndrome, and Type 2 Diabetes
    Pillai, Sabitha Sasidharan
    Gagnon, Charles A.
    Foster, Christy
    Ashraf, Ambika P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (11) : 2709 - 2719
  • [48] Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study
    Yi Guo
    Solomon K. Musani
    Mario Sims
    Thomas A. Pearson
    Mark D. DeBoer
    Matthew J. Gurka
    Diabetology & Metabolic Syndrome, 10
  • [49] Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes
    Grayson, B. L.
    Wang, L.
    Aune, T. M.
    GENES AND IMMUNITY, 2011, 12 (05) : 341 - 351
  • [50] Redox changes in obesity, metabolic syndrome, and diabetes
    Korac, Bato
    Kalezic, Andjelika
    Pekovic-Vaughan, Vanja
    Korac, Aleksandra
    Jankovic, Aleksandra
    REDOX BIOLOGY, 2021, 42